27
Jan

Morphine, a drug commonly used to manage pain in premature babies, has been linked to decreased growth in the cerebellum, resulting in both physical and cognitive impairments, a new study led by NeuroDevNet researcher Dr. Jill Zwicker has found.

The problem is, the alternatives — using another drug like fentanyl, or not providing any pain relief medication — may pose similar risks to neonatal brain development.

>>
21
Jan

Leading FASD researchers have updated Canadian diagnostic guidelines, with a cross-lifespan approach that acknowledges the thousands of individuals who have struggled past childhood without benefit of intervention.

The guideline, appearing in late December 2015 in the Canadian Medial Association Journal, provides recommendations specifically aimed at multidisciplinary diagnostic teams.

>>
13
Jan

Findings from two of the studies1,2 help address one of the central questions that plague clinicians who diagnose autism, according to Dr. Alycia Halliday of the Autism Science Foundation - that is, “the degree to which symptoms may change over time, both in the short term and the long term.”

>>